D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

Name of the Condition

• Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

Summary

Severe combined immunodeficiency (SCID) with low T- and B-cell numbers is a rare, life-threatening inherited disorder characterized by profound defects in both cellular and humoral immunity, leading to extreme susceptibility to infections. This condition results from genetic mutations that disrupt the development or function of immune cells, particularly T cells and B cells, impairing the body's ability to mount effective immune responses. The low numbers of these critical immune cells further compromise the body's ability to fight off pathogens.

Causes

SCID with low T- and B-cell numbers is caused by genetic mutations affecting genes critical for immune cell development and function. These mutations disrupt signaling pathways, cell maturation, or enzyme activity essential for lymphocyte production. Inheritance is typically autosomal recessive, though specific genetic mechanisms may vary by subtype. The condition arises from errors in DNA that impair the body's ability to generate functional immune cells.

Risk Factors

• Genetic predisposition, often with a family history of immunodeficiency disorders.
• Consanguinity (parents who are closely related) increasing the risk of autosomal recessive forms.
• Certain ethnic backgrounds with higher prevalence of specific genetic mutations.

Symptoms

• Recurrent, severe, or persistent infections (e.g., bacterial, viral, fungal).
• Failure to thrive or delayed growth in infants and children.
• Chronic diarrhea or gastrointestinal issues.
• Persistent thrush (oral candidiasis).
• Respiratory infections that do not respond to standard treatments.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory testing, and genetic analysis. Blood tests typically show significantly reduced T-cell and B-cell counts, along with impaired immune function. Flow cytometry may be used to assess lymphocyte subsets, and genetic testing can identify specific mutations. Newborn screening programs in some regions may detect low T-cell receptor excision circles (TRECs), a marker for SCID.

Treatment Options

• Hematopoietic stem cell transplantation (HSCT), the primary curative treatment, to restore immune function.
• Gene therapy for specific genetic subtypes, where available.
• Prophylactic antibiotics, antifungals, and antivirals to prevent infections.
• Immunoglobulin replacement therapy to support humoral immunity.
• Isolation in a sterile environment to reduce infection risk before definitive treatment.

Prognosis and Follow-Up

With early diagnosis and treatment, outcomes can improve significantly. HSCT or gene therapy may restore immune function, allowing for normal development and reduced infection risk. However, without treatment, the condition is fatal within the first year of life due to severe infections. Long-term follow-up is essential to monitor immune reconstitution, manage complications, and address potential late effects of therapy.

Complications

• Severe, life-threatening infections (e.g., pneumonia, sepsis).
• Graft-versus-host disease (GVHD) in transplant recipients.
• Organ damage from chronic infections.
• Developmental delays or growth failure if untreated.
• Increased risk of malignancies due to impaired immune surveillance.

Lifestyle & Prevention

• Strict infection control measures, including avoiding exposure to sick individuals and practicing good hygiene.
• Vaccination schedules may need adjustment, as live vaccines are contraindicated.
• Nutritional support to address failure to thrive.
• Genetic counseling for families to understand inheritance risks and options for future pregnancies.

When to Seek Professional Help

Seek immediate medical attention if experiencing recurrent or severe infections, unexplained fever, or signs of failure to thrive. Early intervention is critical to prevent life-threatening complications. Consult a specialist in immunology or pediatric infectious diseases for evaluation and management.

Tips for Medical Coders

When coding for D81.1 (Severe combined immunodeficiency [SCID] with low T- and B-cell numbers), ensure documentation supports the specific subtype and confirms low T- and B-cell counts. Verify that the diagnosis aligns with clinical findings, such as recurrent infections or laboratory evidence of immunodeficiency. Accurate coding requires clear documentation of the condition's presentation and any associated genetic or laboratory results.